LCM
Lynx1 Capital Management Portfolio holdings
AUM
$346M
This Quarter Return
+8.74%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
+$120M
(+3.7%)
Cap. Flow
-$338K
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
97.95%
Holding
14
New
1
Increased
8
Reduced
4
Closed
1
Top Buys
| 1 |
Merus
MRUS
|
$3.92M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$1.4M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$1.35M |
| 4 |
Structure Therapeutics
GPCR
|
$547K |
| 5 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
$424K |
Top Sells
| 1 |
Cabaletta Bio
CABA
|
$3.07M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$2.47M |
| 3 |
BLU
BELLUS Health Inc.
BLU
|
$1.64M |
| 4 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$831K |
| 5 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$203K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
1
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $24.2M | 20.18% |
3,136,173
+10,000
| +0.3% | +$77.2K |
|
|
2
Cabaletta Bio
CABA
$133M
| $20.3M | 16.92% |
2,454,627
-371,349
| -13% | -$3.07M |
|
|
3
Merus
MRUS
$4.98B
| $19.6M | 16.38% |
1,067,723
+213,132
| +25% | +$3.92M |
|
|
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $13.8M | 11.54% |
2,214,250
+215,833
| +11% | +$1.35M |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $11.9M | 9.96% |
1,369,927
-283,568
| -17% | -$2.47M |
|
|
PVLA
6
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $6.9M | 5.75% |
7,067,718
+1,439,133
| +26% | +$1.4M |
|
|
THRX
7
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $6.76M | 5.64% |
761,258
-22,900
| -3% | -$203K |
|
|
BLU
8
DELISTED
BELLUS Health Inc.
BLU
| $6.24M | 5.2% |
866,646
-227,254
| -21% | -$1.64M |
|
|
PRDS
9
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $4.39M | 3.66% |
3,324,061
+320,959
| +11% | +$424K |
|
10
Passage Bio
PASG
$22.7M
| $3.26M | 2.72% |
3,407,598
+51,681
| +2% | +$49.5K |
|
11
Neurogene
NGNE
$264M
| $1.7M | 1.42% |
2,428,323
+137,190
| +6% | +$96K |
|
|
12
Structure Therapeutics
GPCR
$1.11B
| $547K | 0.46% |
+23,000
| New | +$547K |
|
13
Pharvaris
PHVS
$1.39B
| $211K | 0.18% |
26,225
+900
| +4% | +$7.25K |
|
|
WHWK
14
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.1M
| – | – |
-64,739
| Closed | -$831K |
|